Written and maintained by CASRAI Editorial Board
Last updated
Medicare Advantage Star Ratings are a federal quality and performance evaluation system administered annually by the Centers for Medicare & Medicaid Services (CMS) under 42 CFR §§ 422.160–422.166 (Part C) and 42 CFR §§ 423.180–423.186 (Part D) to grade Medicare Advantage (MA) and Prescription Drug Plan (PDP) contracts on a 1.0-to-5.0 star scale in half-star increments. By combining clinical quality indicators from the Healthcare Effectiveness Data and Information Set (HEDIS), patient experience responses from the CAHPS survey for Medicare Advantage, patient-reported functional outcomes from the Health Outcomes Survey (HOS), and CMS administrative audit data, Star Ratings directly govern multibillion-dollar Quality Bonus Payments (QBPs) under Social Security Act § 1853(o).
What Is Medicare Advantage Star Ratings?
Authorized by the Affordable Care Act (ACA) of 2010 and published every October on the CMS Medicare Plan Finder ahead of the Annual Election Period (AEP), the Star Ratings system evaluates roughly 40 unique Part C (medical services) and Part D (outpatient prescription drug) quality measures across nine operational domains. Contracts offering both medical and drug coverage (MA-PDs) receive three distinct summary scores:
- Part C Summary Rating: Aggregates clinical process, intermediate outcome, patient experience, and access measures across preventive care, chronic disease management, and health plan operations.
- Part D Summary Rating: Aggregates prescription drug plan call center performance, drug pricing accuracy, Medication Therapy Management (MTM) completion rates, and triple-weighted chronic medication adherence (Proportion of Days Covered
PDC ≥ 80%) for oral antidiabetics, renin-angiotensin system (RAS) antagonists, and statins. - Overall MA-PD Star Rating: Combines all eligible Part C and Part D measures, adjusted by the contract’s improvement score, the Categorical Adjustment Index (CAI), and (transitioning in 2027) the Health Equity Index (HEI) reward.
Measure Sources and Weighting Hierarchy (HEDIS, CAHPS, HOS, and CMS Administrative Data)
Under 42 CFR § 422.166(e), CMS assigns differential numerical weights (1x, 2x, 3x, or 5x) to individual Star measures according to their clinical and patient-safety impact:
| Measure Category & Data Source | CMS Weight | Representative Star Measures & Clinical Specifications |
|---|---|---|
| Process Measures (HEDIS / NCQA) | 1x Weight | Breast Cancer Screening, Colorectal Cancer Screening, Annual Flu Vaccine, Osteoporosis Management in Women Who Had a Fracture, Eye Exam and Kidney Health Evaluation for Patients With Diabetes. |
| Patient Experience, Complaints & Access Measures (CAHPS Survey & CMS Admin) | 2x Weight | CAHPS Medicare Advantage survey composites (Getting Needed Care, Getting Appointments and Care Quickly, Customer Service, Care Coordination, Rating of Health Care Quality, Rating of Health Plan), Members Choosing to Leave the Plan, Appeals Auto-Forward/Upheld, and Call Center Foreign Language Interpreter/TTY availability. (Note: CMS adjusted CAHPS/access weight from 4x back to 2x beginning with the 2024 Star Ratings). |
| Outcome & Intermediate Outcome Measures (HEDIS, HOS & PDE Claims) | 3x Weight | Controlling High Blood Pressure (<140/90 mmHg), Glycemic Status Assessment for Patients With Diabetes (HbA1c/GMI ≤9.0%), Plan All-Cause Readmissions (PCR), HOS Improving or Maintaining Physical and Mental Health, and Part D Medication Adherence (PDC ≥ 80% for Diabetes, Hypertension, and Cholesterol). |
| Part C & Part D Quality Improvement Measures | 5x Weight | Statistically significant net year-over-year improvement across eligible Part C and Part D measures (subject to the hold-harmless rule for contracts already at ≥4.0 stars). |
How Cut Points Are Calculated: Hierarchical Clustering, 5% Guardrails, and Tukey Outlier Deletion
For non-CAHPS measures, CMS does not use predetermined static thresholds; instead, under 42 CFR § 422.166(a)(2), CMS derives the 1-to-5 star cut points dynamically from the empirical distribution of contract scores using a three-step statistical pipeline:
- Tukey Outer-Fence Outlier Deletion: Effective beginning with the 2024 Star Ratings, CMS removes extreme statistical outliers before clustering by computing the 25th percentile (
Q1), 75th percentile (Q3), and Interquartile Range (IQR = Q3 − Q1) of raw contract scores and deleting any score falling outside the Tukey outer fences:[Q1 − 3.0 × IQR, Q3 + 3.0 × IQR]. Because most extreme outliers in healthcare quality data lie on the low-performing tail, removing them compresses the remaining distribution upward and raises the 3-, 4-, and 5-star cut points. - Mean Resampling and Hierarchical Clustering: CMS randomly divides the non-outlier contract scores into 10 equal sub-samples, applies Ward’s minimum-variance hierarchical clustering algorithm to partition each sub-sample into 5 star groups, and averages the resulting cluster boundaries across the 10 resamples.
- 5% Bidirectional Cap Guardrails: To prevent abrupt year-over-year threshold jumps, CMS enforces a 5-percentage-point guardrail cap (for measures scored on a 0–100 scale) limiting how far any cut point can move upward or downward relative to the prior year’s threshold. (CAHPS survey measures instead use relative percentile distribution and t-test significance testing against national means.)
How Is Medicare Advantage Star Ratings Used in Clinical Research and Healthcare?
1. Quality Bonus Payments (QBPs) and Rebate Retention
Under Social Security Act § 1853(o), an MA contract’s overall Star Rating directly determines federal capitation benchmarks and beneficiary rebate percentages:
- 4.0, 4.5, and 5.0 Star Contracts: Receive a 5% Quality Bonus Payment (QBP) added to their county benchmark rate (up to 10% in qualifying double-bonus urban counties) and retain a higher share of the savings between their bid and the benchmark as rebates to fund supplemental benefits (65% rebate for 3.5 and 4.0 stars; 70% rebate for 4.5 and 5.0 stars, compared with 50% for ≤3.0 stars).
- 5-Star Special Enrollment Period (SEP): Contracts achieving 5.0 stars earn a year-round Special Enrollment Period allowing Medicare beneficiaries in their service area to switch into the 5-star plan outside the fall open enrollment window.
- Low-Performing Icon (LPI) and Termination Authority: Contracts scoring below 3.0 stars in Part C or Part D for three consecutive years receive a public Low-Performing Icon and face CMS contract termination authority.
2. Health Services Research, EHR Clinical Quality Measures (eCQMs), and the Health Equity Index (HEI)
In health services research and primary care chronic care management workflows, health systems link EHR flowsheets and HL7 FHIR R4 Digital Quality Measures (dQMs) to NCQA HEDIS specifications to close preventive and glycemic care gaps before year-end chart abstraction. Survey methodologists also study CAHPS response bias and psychometric validity alongside good survey questions design, while regulatory teams evaluate coverage alignment across Medicare Clinical Trial Policy (NCD 310.1) and Medicare device coverage pathways. Finally, under 42 CFR § 422.166(f)(3), CMS replaces the historical Reward Factor (starting with the 2027 Star Ratings using 2024–2025 measurement years) with the Health Equity Index (HEI)—offering up to +0.4 stars to contracts that achieve top-tier clinical and experience outcomes among enrollees with Social Risk Factors (Dual Eligible, Low-Income Subsidy, or Disabled status).
Frequently Asked Questions
What is Medicare Advantage Star Ratings?
Medicare Advantage Star Ratings are CMS’s annual 1.0-to-5.0 star quality grading system (codified at 42 CFR §§ 422.160–422.166) that evaluates Medicare Advantage (Part C) and Part D prescription drug plans across HEDIS clinical measures, CAHPS patient experience surveys, HOS functional outcome surveys, and CMS operational audits.
How is Medicare Advantage Star Ratings used in clinical research and healthcare?
In healthcare operations, achieving 4.0 or more stars unlocks a 5% federal Quality Bonus Payment (QBP) and 65%–70% rebate retention under Social Security Act § 1853(o), driving EHR care-gap closure for triple-weighted blood pressure, diabetes, readmission, and medication adherence measures. In health services research, Star Ratings datasets are used to evaluate value-based care interventions, Tukey outlier cut-point shifts, and health disparity reductions under the CMS Health Equity Index (HEI).
Sources
- U.S. Government Publishing Office / eCFR: 42 CFR §§ 422.160–422.166 — Medicare Advantage Quality Rating System (Measure Weights, Tukey Outlier Deletion, Guardrails, and Health Equity Index).
- Centers for Medicare & Medicaid Services (CMS): Medicare 2024 & 2025 Part C & D Star Ratings Technical Notes and Social Security Act § 1853(o) (42 U.S.C. § 1395w-23(o)).
- National Committee for Quality Assurance (NCQA) & Agency for Healthcare Research and Quality (AHRQ): HEDIS Volume 2 Technical Specifications and Medicare Advantage CAHPS Survey Protocols.
